UARK 2015-03 A Phase II Trial of a Novel Proteasome/IMiD Combination
Status:
Withdrawn
Trial end date:
2017-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the efficacy of Ixazomib when combined with
Pomalidomide and Dexamethasone, in terms of overall response rate in subjects with relapsed
Multiple Myeloma